Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 860,425 | 509,089 | 230,064 | 840,094 | 619,680 |
| Depreciation Amortization | 10,647 | 5,324 | 27,026 | 21,696 | 16,353 |
| Accounts receivable | 2,014 | -1,200 | -4,744 | 33,466 | 32,962 |
| Other Working Capital | 574,854 | 443,811 | 414,802 | 273,058 | 193,175 |
| Other Operating Activity | 193,714 | 76,813 | 1,476,832 | 405,735 | 173,052 |
| Operating Cash Flow | $1,641,654 | $1,033,837 | $2,143,980 | $1,574,049 | $1,035,222 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -1,741,640 | -21,215 | -21,215 |
| PPE Investments | -662,151 | -601,705 | -21,215 | -1,491,399 | -175,093 |
| Purchase Of Investment | -18,966 | -15,979 | -812,109 | -701,287 | -379,862 |
| Sale Of Investment | 59,158 | 59,158 | 1,545,543 | 769,738 | 557,157 |
| Investing Cash Flow | $-621,959 | $-558,526 | $-1,029,421 | $-1,444,163 | $-19,013 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,625 | 3,592 | 7,192 | 5,840 | 3,978 |
| Common Stock Repurchased | -134,442 | N/A | N/A | N/A | N/A |
| Dividend Paid | -427,552 | -213,965 | -950,701 | -685,146 | -453,198 |
| Other Financing Activity | 0 | 0 | -1,347 | 0 | 0 |
| Financing Cash Flow | $-557,369 | $-210,373 | $-944,856 | $-679,306 | $-449,220 |
| Beginning Cash Position | 1,710,751 | 1,710,751 | 1,541,048 | 1,541,048 | 1,541,048 |
| End Cash Position | 2,173,077 | 1,975,689 | 1,710,751 | 991,628 | 2,108,037 |
| Net Cash Flow | $462,326 | $264,938 | $169,703 | $-549,420 | $566,989 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,641,654 | 1,033,837 | 2,143,980 | 1,574,049 | 1,035,222 |
| Capital Expenditure | -662,151 | -601,705 | -21,215 | -1,491,399 | -175,093 |
| Free Cash Flow | 979,503 | 432,132 | 2,122,765 | 82,650 | 860,129 |